Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder Published Date April 9, 2022 Szabados B, Kockx M, Assaf ZA, et al. European Urology. Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen